Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boulder/denver blog main
boulder/denver top stories
deals
4
×
detroit blog main
detroit top stories
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
4
×
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boston top stories
cancer
cancer immunotherapy
clinical trials
fda
johnson & johnson
medicaid
novartis
alnylam pharmaceuticals
astrazeneca
biogen
What
roundup
bio
alzheimer’s
drug
acquisitions
ahead
ambien
american
announced
annual
asco
attendees
attention
biotech
camp’s
cancer
cash
ceo
chicago
city
clinical
collabs
combinations
community’s
companies
congress
covid
daniel
days
deal
democrats
different
divided
elections
expanding
fail
fallout
focus
gene
gilead
Language
unset
Current search:
sanofi
×
deals
×
" detroit top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More